Anouk Donners

CHAPTER DosEmi study protocol: A phase IV, multicenter, open-label, crossover study to evaluate noninferiority of pharmacokineticguided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A Anouk A.M.T. Donners Konrad van der Zwet Toine C.G. Egberts Karin Fijnvandraat Ron A.A. Mathot Ilmar Kruis Marjon H. Cnossen Roger E.G. Schutgens Rolf T. Urbanus Kathelijn Fischer Submitted